community-acquired infections

Antibiotics and community-acquired lower respiratory tract infections. To whom? Which one?

Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):27-38

10.36488/cmac.2019.1.27-38

This paper discusses an etiology, patient characteristics, and antimicrobial resistance surveillance data, as well as other factors which help to determine indications for administration and choice of antibiotics for the treatment of patients with …

Diagnosis treatment and prophylaxis of community-acquired bacterial meningitis: the review of the guidelines of European Society for Clinical Microbiology and Infectious Diseases

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):102-115

Community-acquired bacterial meningitis is one of the most serious infectious lesions of the central nervous system that can quickly lead to death in even previously healthy patients with inadequate treatment. The article provides an overview of the …

Community-Acquired MRSA – New Problem of Antimicrobial Resistance

Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(1):32-46

Staphylococcus aureus remains one of the most important human pathogens. Special attention is paid to a new problem – emerging and spreading of methicillin$ resistant strains of S. aureus in the community (CAMRSA). The main differences between …